Transdermal Antihyperthyroid Formulation for Cats
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antihyperthyroid drug formulations for cats, such as methimazole and carbimazole, face challenges with transdermal absorption, leading to inconsistent drug concentration and skin irritation, and require frequent administration, which can be stressful for animals and difficult for owners to manage.
Innovation Solution
A transdermal formulation incorporating antihyperthyroid drugs like carbimazole or methimazole, combined with penetration enhancers like fatty acids, terpenes, and glycol ethers, to improve skin absorption and stability, allowing for once-daily application and reduced stress for both animals and owners.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If transdermal formulation is used to reduce administration frequency, then ease of operation is improved, but drug absorption consistency deteriorates
Solution Approach 1:
The patent modifies the chemical parameters of the formulation by incorporating specific penetration enhancers (fatty acids, terpenes, glycol ethers) to change the physical-chemical properties of the drug-skin interface. This enables consistent transdermal absorption while maintaining once-daily application, resolving the contradiction between ease of operation and absorption reliability.
Solution Approach 2:
The patent creates a composite transdermal formulation combining antihhyperthyroid drugs with penetration enhancers and other excipients in specific ratios. This composite material approach ensures both ease of administration (once daily) and reliable absorption by synergistically combining multiple components that address different aspects of transdermal delivery.
2Ease of operation
If transdermal formulation is used to reduce stress, then ease of operation is improved, but skin irritation worsens
Solution Approach 1:
The patent carefully controls the concentration and type of penetration enhancers to optimize the balance between absorption enhancement and skin tolerance. By adjusting these parameters, the formulation achieves effective drug delivery while minimizing skin irritation, allowing stress-free once-daily application.
Solution Approach 2:
The penetration enhancers act as intermediary substances that facilitate drug absorption through the skin without causing significant irritation. These mediators (fatty acids, terpenes, glycol ethers) temporarily modify skin permeability to enable drug passage while being well-tolerated by the skin, thus reducing overall stress on the animal.
3Reliability
If penetration enhancers are added to improve absorption, then transdermal delivery is improved, but formulation complexity worsens
Solution Approach 1:
The patent simplifies the formulation complexity by selecting penetration enhancers that can be incorporated into existing transdermal vehicle systems. By optimizing the concentration parameters of these enhancers and their compatibility with common excipients, the formulation achieves reliable transdermal absorption without requiring overly complex formulation structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation maintains drug plasma levels longer than traditional oral tablets, reducing the need for frequent dosing and minimizing stress, while ensuring effective transdermal delivery and stability over time.
Implementation Method 1
A transdermal formulation incorporating antihhyperthyroid drugs like carbimazole or methimazole, combined with penetration enhancers like fatty acids, terpenes, and glycol ethers, to improve skin absorption
Data Source
AI summary
The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.